SEC Form 4 · accession 0001104659-17-054928
PRA Health Sciences, Inc. · PRAH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Linda Baddour
Officer — Executive VP & CFO
Period of report
Aug 29, 2017
Accepted (ET)
Aug 31, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613859
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $75.81 | Aug 29, 2017 | A | 30,000 | A | — | Aug 29, 2027 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The options vest as follows: (a) 20% on each of August 29, 2018 and August 29, 2019, and (b) 30% on each of August 29, 2020 and August 29, 2021, subject to the holder's continued service through each applicable vesting date.